In vitro interaction of the pentasaccharide idraparinux (SanOrg 34006) with unfractionated heparin

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 9, 2003, Pages 2054-2056

  Gouin Thibault, I ^a   Dingler, E ^c   Maris, F A ^d   Samama, M M ^b  

^a HÔPITAL CHARLES FOIX   (France)

^b HÔTEL DIEU   (France)

^c Organon Development GmbH   (Germany)

^d NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; IDRAPARINUX; OLIGOSACCHARIDE;

BLOOD CLOTTING; DRUG EFFECT; DRUG INTERACTION; HUMAN; LETTER; PARTIAL THROMBOPLASTIN TIME;

BLOOD COAGULATION; DRUG INTERACTIONS; HEPARIN; HUMANS; OLIGOSACCHARIDES; PARTIAL THROMBOPLASTIN TIME;

EID: 1942487508     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00384.x     Document Type: Letter

References (8)

1. Hérault JP, Bernat A, Roye F, Michaux C, Schaeffer, Bono F, Petitou M, Herbert JM. Pharmacokinetics of new synthetic heparin mimetics. Thomb Haemost 2002; 87: 985-9.
2. Petitou M, Duchaussoy P, Herbert JM, Due G, El Hajji M, Branellec JF, Donat F, Necciari J, Cariou R, Bouthier J, Garrigou E. The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa. Semiti Thromb Haemost 2002; 28: 393-402.
3. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR, for the Steering Committees of the Pentasaccharide Orthopedic Prophylaxis Studies. Fondaparinux versus enoxaparin for the prevention of venous throm- boembolism in major orthopedic surgery. A meta-analysis of 4 rando mized double-blind studies. Arch Intern Med 2002; 162: 1833-4-0.
4. Herbert JM, Hérault JP, Bernat A, van Amsterdam RGM, Lormeau JC, Petitou M, van Boeckel C, Hoffmann P, Meuleman DG. Biochemical and pharmacological properties of SanOrg 34006, a potent long-acting syn thetic pentasaccharide. Blood 1998; 91: 4197-205.
5. Walenga JM, Bara L, Hopppensteadt D, Choay J, Fareed J, Samama MM. AT-III as a rate limiting factor for the measurement of pentasaccharide in laboratory assays. Thomb Haemost 1991; 67: 1314 (Abstract).
6. Chu AJ, Wang ZG, Raicu M, Beydoun S, Ramos N. Protamine inhibits tissue factor-initiated extrinsic coagulation. Br J Haematol 2001; 115: 392-9.
7. Daub AN, Ahsan A, Iqbal O, Walenga JM, Silver PJ, Ahmad S, Fareed J. Synthetic heparin pentasaccharide depolymerisation by heparinase I: molecular and biological implications, din Appi Thromb Hemost 2001; 7: 58-64.
8. Yu G, LeBrun L, Gunay NS, Hoppensteadt D, Walenga JM, Fareed J, Linhardt RJ. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site. Thromb Res 2000; 100: 549-56